Seth Benkel, M.D.

Hospital and Academic Affiliations

 

Good Samaritan Hospital, Suffern, NY

Chief of Hematology 

 

Member of the bloodless surgical program at Good Samaritan Hospital
                  

​

Education

2003-2006 

Montefiore Medical Center, Bronx, NY
Fellowship, Hematology-Oncology

​

2000-2003 

Beth Israel Medical Center, New York, NY
Residency, Internal Medicine

​

1996-2000 

SUNY Health Science Center at Brooklyn, Brooklyn, NY

 

1992-1996 

Brandeis University, Waltham, MA

BA, Psychology

 

​

Certification

2003  Diplomat of the American Board of Internal Medicine
2006, 2016 Board certified - Hematology
2006, 2016 Board certified - Oncology

​

​

Publications 

Forman R, Benkel S, Novik Y, Tsai HM. Presence of ADAMTS 13 activity in a patient with metastatic cancer and thrombotic microangiopathy. Acta Hematologica 2003; 109: 150-152.

​

​

Hematology and Oncology Presentations

April 2002 - Breast cancer, Estrogen, and the Selective estrogen receptor modulators

July 2003 - Thrombotic microangiopathy in the cancer patient

October 2003 - Optimal management of residual nonseminomatous germ cell tumors

August 2004 - Acute lymphoblastic leukemia

August 2004 - Aplastic Anemia

December 2004 - Red Blood Cell substitutes

April 2005 - Management of rising serum PSA following radical prostatectomy

March 2006 - Anemia of Chronic Disease in the cancer patient

November 2006 - Heparin Induced Thrombocytopenia